Isis spin-out Organox closes series D round
OrganOx, a late-stage medical device company focused on increasing the quality and supply of organs for transplantation, has announced that it has closed a Series D Investment round.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
OrganOx, a late-stage medical device company focused on increasing the quality and supply of organs for transplantation, has announced that it has closed a Series D Investment round.
A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery.
Next generation carbon nanomaterials such as graphene, carbon nanotubes and fullerenes, with their unique physical properties, have been hailed as “miracle materials”.
Oxford-based Immunocore has announced that its immune therapy has shown promising early signs of efficacy in a Phase I trial in advanced melanoma patients.
Reviving a gene which is “turned down” after birth is potentially the key to treating Duchenne Muscular Dystrophy, an untreatable muscle-wasting condition which affects one in every 3,500 boys.
Phillip Campbell of Oxford Innovation Society member Milton Park talks to Immunocore’s Eva-Lotta Allan.
Oxford University Innovation spin-out Kepler Energy has been awarded £30,000 at the prestigious Shell Springboard Awards.
The Awards recognise and reward individuals and small teams who have harnessed the potential of their excellent research.
The trial involves Isis spin-outs, the University and the Oxford University Hospitals NHS Trust.
Acquisition by US games company Zynga one of the largest for a European spin out.